Sign up
Pharma Capital
Market: AIM
52-week High/Low: 11.50p / 3.37p
Sector: Pharma & Biotech
Market Cap: 266.63M

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.

Oxford BioMedica's products use genes as the mediators of a therapeutic effect and/or immune response. The Company has a platform of gene delivery technologies, which are predominately based on highly engineered viral systems. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how.

Oxford BioMedica is traded in the ISDX Exchange HERE

Oxford Biomedica

Interactive graph

col 3
col 4
col 5
col 6

Oxford Biomedica Timeline

View All

Market Reports Including OXB


Executive video interviews


© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.